Comunidad Bioquimica

20/03/2023

20/03/2023

20/03/2023

Biology of S*x Differences

14/11/2019

Pinkal Desai, MD, discusses the factors a practicing physician should consider when selecting an appropriate induction therapy for patients with acute myeloid leukemia.

07/09/2019

Keith T. Flaherty, MD, discusses the combination regimens and the potential role for a 3-drug regimen as treatment for patients with melanoma. He says investigators have been searching for new combination strategies beyond the combination of BRAF and MEK inhibitors.

13/07/2019

Mark G. Kris, MD, discusses the importance of delaying relapse in patients with EGFR-positive non–small cell lung cancer. He shares the significance of the findings from the phase III RELAY trial, where the goal was to delay the time to relapse by adding ramucirumab to erlotinib.

08/07/2019

Josep M. Llovet, MD, PhD, discusses the evolution of treatment options for patients with hepatocellular carcinoma.

05/07/2019

Bradley J. Monk, MD, noted the FDA’s approval of the biosimilar agent bevacizumab-awwb across multiple indications including metastatic colorectal cancer, non–small cell lung cancer, glioblastoma, metastatic renal cell carcinoma, and cervical cancer, but he wondered aloud why ovaria...

21/06/2019

"What's the secret to a stress-free life?" Oliver Smithies, awarded the 2007 Nobel Prize in Physiology or Medicine, lectured at Shanghai Jiao Tong University...